As of Dec 2025 ยท from Reg CF Offering (2025) ยท pre-money + amount raised, not a traded price
Total raised
$5,183,822
Across 3 rounds since 2023
Latest share price
$3.79
Reg CF Offering (2025) offering price
Financials
FY2020โFY2025 ยท from SEC filings ยท hover any figure for its source
$1.5M
$165K
2020
$1.5M
$160K
2021
$2.4M
$186K
2022
$7.3M
$445K
2023
$16.7M
$256K
2024
$18.4M
โ$1.9M
2025
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$1,498,484
$1,521,733
$2,409,670
$7,311,191
$16,651,458
$18,359,881
Cost of goods sold
$622,247
$622,247
$954,751
$2,482,547
$6,577,187
$8,469,198
Gross margin
58%
59%
60%
66%
61%
54%
Net income
$165,246
$160,296
$186,351
$444,983
$256,432
-$1,857,963
Taxes paid
$1,181
$0
$0
$0
$0
$0
Balance sheet
Cash
$167,666
$167,666
$282,031
$2,149,126
$2,750,554
$1,747,700
Accounts receivable
$635
$635
$0
$0
$0
$43,526
Total assets
$239,001
$239,000
$490,697
$4,884,419
$8,277,831
$6,362,534
Short-term debt
$73,331
$113,987
$11,734
$25,466
$574,743
$705,431
Long-term debt
$131,900
$120,166
$120,166
$187,074
$0
$1,625,147
Total liabilities
$205,231
$234,153
$599,229
$212,540
$574,743
$2,330,578
Other
Headcount
โ
9
9
24
9
25
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.